Information Provided By:
Fly News Breaks for June 10, 2015
BAX, CTIC
Jun 10, 2015 | 14:21 EDT
After CTI BioPharma (CTIC) amended its agreement with Baxter's (BAX) Baxalta to accelerate anticipated milestones related to pacritinib, Piper Jaffray said the deal eliminates the firm's expectation for an equity financing round to be needed this quarter. The firm added that it thinks the deal signals a high level of confidence in the program from the larger partner and reiterates its Overweight rating and $8 target on CTI shares.
News For CTIC;BAX From the Last 2 Days
There are no results for your query CTIC;BAX